Table 1 Characteristics of participants (n = 76. values are absolute frequencies or means)

From: Weekly self-measurement of FEV1 and PEF and its impact on ACQ (asthma control questionnaire)-scores: 12-week observational study with 76 patients

Overall 76 (100%)
Women 57 (75%)
Diagnosed by pulmologist 58 (76%)
Diagnosed by GP 18 (24%)
Recruited by specialist 36 (47%)
Recruited by GP 40 (53%)
Smokers 14 (18%)
Mean age (overall) 45.6 years (SD = 15.4)
Mean BMI (overall) 26.0 mg/m2 (SD = 5.0)
Previous asthma training 52 (68%)
ACQ 6 week 1  
Mean 1.3 (SD 1.0)
≤0.75 34 (45%)
0.76–1.49 19 (25%)
≥1.5 23 (30%)
FEV1 mean week 1 2.4 (SD 0.7)
FEV1 %-predicted mean week 1 80.5% (SD 19.1%)
PEF mean week 1 (mornings/evenings) 404 (SD 96) /390 (SD 98)
PEF %-predicted mean week 1 90.9% (SD 21.9%)
Asthma medication  
ICS 63 (83%)
LABA 45 (59%)
RABA 52 (68%)
Others 11 (15%)
Controller 70 (92%)
Reliever 45 (59%)
Controller + reliever 38 (50%)
None 1 (1.3%)
  1. GP general practitioner, BMI body mass index, SD standard deviation, ACQ 6 = Asthma Control Questionnaire version with 6 items, FEV1 = forced expiratory volume in 1 second, PEF peak expiratory flow, ICS inhalative corticosteroid, LABA long-acting beta-2 agonist, RABA rapid-acting beta-2 agonist